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Selective chemical modiﬁcation of DNAwith
alkoxy- and benzyloxyamines†
Lorina Gjonaj and Gerard Roelfes*
A new method for the selective chemical modiﬁcation of DNA at cytosine nucleobases using alkoxy- and
benzyloxyamines is presented. It is shown that in particular benzyloxyamines are eﬀective DNA modifying
agents, giving rise to almost exclusive formation of the mono addition products. By using a bifunctional
derivative, that is, p-azidobenzyloxyamine hydrochloride, an azide moiety, which is a convenient handle
for further functionalization, could be introduced into the DNA. The azido modiﬁed DNA was then further
reacted in a copper(I)-monophos catalysed 1,3-dipolar cycloaddition. These results illustrate the potential
of the presented method for application in site and chemo-selective modiﬁcation of DNA.
Introduction
The unique chemical and physical properties of DNA have
paved the way for widespread application of this molecule far
beyond its natural role as carrier of genetic information. The
selective recognition of complementary nucleobases, resulting
in Watson–Crick base pairing, has proven to be a very powerful
tool for the assembly of complex DNA structures.1 For many
applications, however, additional chemical functionalities
need to be introduced into the DNA. Functionalized DNAs
have found applications in diverse fields such as nanotechno-
logy, synthesis and catalysis and chemical biology, for example
as DNA sensors, for electrochemical analysis,2 DNA labelling,3
DNA-based catalysis,4 hybrid materials and drug delivery
systems5 and many more.
The most common method used for the preparation of
functionalized DNAs involves solid phase synthesis, which is
convenient for obtaining small quantities of short oligonucleo-
tides containing novel functionalities.6 Another popular
approach for the preparation of functionalized DNA involves
the enzymatic incorporation of modified nucleotide triphos-
phates (dNTPs) by DNA polymerases.7
Both these approaches have in common that they require
multistep chemical synthesis of the necessary nucleotide
building blocks, which is laborious and time consuming.
Ideally, it would be possible to introduce a novel chemical
functionality selectively in the DNA in a post-(bio)-synthetic
step. The fact that DNA is built up from only 4 building blocks
that present very similar functional groups makes this a highly
challenging task.
One example of such an approach is the sequence specific
modification of DNA by use of DNA methyltransferase.8 While
this method has enormous potential, it again relies on syn-
thetic nucleotides, that are, S-adenosyl methionine derivatives.9
A limited number of methods for the selective chemical
modification of DNA have been developed. This includes bio-
orthogonal labelling of 5-hydroxymethylcytosine,10 selective
DNA G-quadruplex alkylating agents,11 reaction of cytosine
with bisulfite followed by transamination,12 selective alkylation
of exocyclic amines with rhodium and copper carbenoid com-
plexes,13 and using cisplatin as a covalent anchor for catalyti-
cally active metal complexes.4a,14
Alkoxyamines are frequently used in bioconjugation reac-
tions, also to DNA, albeit that this generally involves reactions
with an introduced bio-orthogonal aldehyde moiety, resulting
in oxime formation.15 However, hydroxyl and methoxyamines
have long been known to modify DNA selectively. This is, for
example, the foundation for their use as mutagenic agents and
in Maxam–Gilbert sequencing.16
Both hydroxyl- and methoxyamine react specifically and
hundred times more eﬃciently with exposed cytosine residues
compared to the other three nucleobases.17 The main products
of this reaction are the result of nucleophilic attack on either
C4 or C6, which are the most electrophilic positions. At high
concentrations of alkoxyamine, commonly the C4 substitution
product A and the double addition product B are obtained as
the main products (Scheme 1). The eﬃciency and the selecti-
vity of the reaction are dependent on the pH, temperature and
concentration.18 Here we report that alkoxyamines, and in par-
ticular benzyloxyamines, are excellent reagents for the selective
mono-functionalization of cytosine in DNA. Moreover, we
show that by using a bifunctional benzyloxyamine derivative
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c5ob00595g
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containing an azide moiety, further functionalization of DNA
can be achieved using azide–alkyne click chemistry.
Results and discussion
Synthesis of alkoxyamines
The alkoxyamines hydrochloride salts 1–7 were used in this
study (Fig. 1). 1, 5 and 6 were available from commercial
sources, 3 and 4 were prepared following literature procedures.19
2 was prepared from decyl bromide (8) by reaction with
N-hydroxyphtalamide in the presence of K2CO3 giving rise to 9
(Scheme 2). This was followed by reaction with hydrazine
hydrate, resulting in the free alkoxyamine 10. Treatment of 10
with HCl [6 M] provided 1-decylhydroxylamine hydrochloride
salt 2.
Azide modified benzyloxyamine 7 was prepared using the
synthetic route outlined in Scheme 3. p-Azido-toluene (12) was
prepared by reacting p-toluidine (11) with NaNO2/HCl and
NaN3. The subsequent bromination reaction was performed
using NBS and AIBN, which did not result in full conversion,
even after 3 days. Treatment of 13 with N-hydroxyphtalamide
in presence of a base yielded 14, which possessed the aminoxy
functionality. Deprotection of 14 with hydrazine hydrate furn-
ished the free alkoxyamine, which was transformed immedi-
ately to the corresponding hydrochloride salt 7.
DNA modification with alkoxyamines
The optimal reaction conditions for DNA modification were
investigated in the reaction of O-methoxyamine·HCl (1) with a
single stranded DNA pentamer with sequence dTACGT (O1),
containing only one cytosine. This reaction gives rise to 2 poss-
ible products: the mono-substituted adduct A and double sub-
stituted product B. A first screening of conditions revealed that
the shortest reaction time and optimal selectivity was achieved
at pH = 4 and a reaction temperature of 50 °C (Table S1†).
Next, the dependence on the concentration of 1 was deter-
mined (Table 1). The highest ratio A/B, i.e. A/B = 12, was
obtained at a final concentration of 1 of 0.5 M (entry 3), but
with relatively low conversions after 8 h. A longer reaction time
resulted in almost full conversion, albeit accompanied by a
small decrease in selectivity (entry 4). Lowering the concen-
tration of 1 further resulted in a decrease of both the ratio A/B
and the reaction rate. Therefore it was concluded that the
optimal conditions to achieve both high conversion and high
selectivity were pH = 4.0, 50 °C and final concentration of 0.5 M
of the methoxyamine (Table 1, entry 4). The products were
purified using reversed phase HPLC and their identity was
confirmed by MALDI-TOF (A m/z = 1507 and B m/z = 1554,
respectively).
Scheme 1 Reaction of hydroxylamine and methoxyamine with
cytosine.
Fig. 1 Alkoxyamines used in this study.
Scheme 2 Synthesis of 2. (i) N-Hydroxyphtalamide, K2CO3, DMF, over-
night, 83%; (ii) hydrazine hydrate, DCM, overnight, 69%; (iii) 10 M HCl,
quantitative.
Scheme 3 Synthesis of azido modiﬁed benzyloxyamine 7. (i) NaNO2,
HCl, NaN3, H2O, 85%; (ii) NBS, AIBN, benzene, 3 days, 69%; (iii) N-hydro-
xyphtalamide, K2CO3, DMF, overnight, 76%; (iv) hydrazine hydrate, DCM,
overnight, 56%; v. Conc. HCl, quantitative.
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Having established the optimal conditions for modifying
DNA with 1, the scope of the reaction was explored using a
variety of other alkoxyamines. First the alkoxyamines 2–4 were
investigated. 2 contains a long alkyl chain and the DNA adduct
potentially can be used for the synthesis of DNA surfactants,
which have found applications in nanotechnology.20 After
optimization it was found that at room temperature (r.t) and at
0.45 M methoxyamine concentration gave the best result with
a ratio A/B of 4 : 1 (Table S2†).
Amino modified DNAs are useful scaﬀolds for derivatiza-
tion.3 The goal here was to modify the DNA with an amino
functionality using amino alkoxyamines. The DNA functionali-
zation with aminoxy aminoalkyl dihydrochlorides, 3 and 4,
was investigated using the optimized conditions found for 1.
Unfortunately, in both cases the reaction times were signifi-
cantly longer and many unidentified side products were
obtained. Even when the final concentration of the modifying
agents was increased to 1.0 M, full conversion was not
obtained after 5 days. The corresponding mono-substituted
products were observed, but due to the fact that the reaction
results in complex product mixtures, this reaction was not
pursued further.
DNA modification with benzyloxyamines
In light of the results described above, it was decided to focus
on aryloxy- and benzyloxyamines. Phenyloxyamine hydrochlo-
ride 5 gave no reaction, even after several days. This suggests
that this reagent is not suﬃciently nucleophilic. In contrast,
excellent results were achieved using benzyloxyamine hydro-
chloride 6. After 48 h, the reaction had almost reached com-
pletion (97% conversion) and the desired mono-substituted
product A was obtained as the major product with an A/B ratio
of 12 : 1 (Table 2, entry 2). Increasing the final concentration of
the alkoxyamine, resulted in a lower ratio compared to entry
2. The product was purified by reversed phase-HPLC, giving
rise to 12% isolated yield.
The product M6A was subjected to an MS/MS analysis to
verify that indeed the cytosine had been modified selectively
(Fig. S2†). Assignment of the peaks resulting from the small
fragments of the product confirmed the presence of unmodi-
fied A, G and T nucleobases; no peaks corresponding to any of
these bases carrying the benzyloxyamino functionality were
found. However, unmodified cytosine fragments were not
observed after fragmentation. Instead, a fragment with m/z =
216.1 was found which corresponds to the benzyloxyamino
modified cytosine nucleobase. Moreover, analysis of the larger
fragments confirmed that A, T and G were not modified (ESI†).
Additionally, the assignment of fragments at m/z 1110.6 and
1279 supports modification at C.
Given the success of modifying oligo 1 with benzyloxyamine
hydrochloride a longer sequence of DNA was tested. The reac-
tion with oligo 2 (dAATACGTG) was investigated using the opti-
mized conditions. The reaction was found to be highly
selective, i.e. the double substituted product could not be
detected, but slow (Table 2, entry 3). After 5 days, 90% conver-
sion was obtained, as determined by HPLC. The product was
purified by preparative RP-HPLC and its identity was con-
firmed by MALDI-TOF (m/z = 2534).
DNA modification with a bifunctional benzyloxyamine
Having established the eﬃcient and selective modification of
DNA with benzyloxyamine, we focused on using the bifunc-
tional benzyloxyamine derivative 7, carrying an azide moiety
that can be used for further functionalization. The reaction
was followed by RP-HPLC and analysed by MALDI-TOF.
Full conversion was obtained after 3 days at 50 °C. The








1 1.25 94 24 3
2 0.75 97 24 3
3 0.5 40 8 12
4 0.5 95 24 9
5 0.25 100 48 6
6 0.1 80 48 4.5
a All experiments were carried out in the presence of oligo 1 [100 µM],
methoxyamine 1 (pH = 4 and 50 °C). bDetermined by RP-HPLC. c Time
after which the samples were taken. dDetermined with RP-HPLC.








1 5 — 3 —
2 6 97 2 12
3 6e 90 5 Only Ag
4 7 f 98 3 Only Ag
a All experiments were carried out with oligo 1 [100 µM] and a final
concentration of alkoxyamine reagent of 0.5 M, at pH = 4 and 50 °C,
unless noted otherwise. bDetermined by RP-HPLC. c Time after which
the samples were taken. d Ratio mono/double substituted products,
determined by RP-HPLC. e Reaction with oligo 2 [100 µM]. f Final
concentration of compound 7 0.25 M. gDisubstituted product B was
not detected.
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modification process was highly selective towards the mono-
substituted product M7A, i.e. formation of the disubstituted
product M7B was not observed. M7A was purified by size exclu-
sion chromatography (75–80% yield).
The azide functionality can be reacted further using either
the Huisgen 1,3-dipolar cycloaddition.21 Thus, DNA labelled
with an azide moiety is an attractive building block for intro-
ducing fluorophores, carbohydrates and ligation to other bio-
molecules.22 The copper catalysed azide–alkyne cycloaddition
procedure that was applied involves a recently reported
copper-monophos catalyst, which has been shown to signifi-
cantly accelerate the reaction.23 This procedure is compatible
with peptides and enzymes and it can be performed in
aqueous media. The reaction was explored using two diﬀerent
alkynes (Scheme 4), phenylacetylene 15 and the fluorescent
alkyne 16, a derivate of dansyl chloride.
Copper(II) sulphate was used as the copper source, which
was reduced to Cu(I) in situ by sodium ascorbate. The mixture
of copper and ligand was added to the solution of the alkyne
and azide, under nitrogen atmosphere. The click reactions
were followed by reversed phase. Full conversion was achieved
within 2 hours in both reactions. The DNA functionalized pro-
ducts, M8A and M9A, were obtained after preparative HPLC in
isolated yields of 14–15% over 2 steps.
Conclusions
A new method for the selective chemical modification of DNA
at cytosine nucleobases using alkoxy- and benzyloxyamines
was developed. The most eﬀective modifying agents were
found to be benzyloxyamines, which proved to give almost
exclusively formation of the mono addition products. By using
a bifunctional derivative, that is, p-azidobenzyloxyamine
hydrochloride, an azide moiety, which is a convenient handle
for further functionalization, could be introduced into the
DNA. The azido modified DNA was then further reacted in a
copper(I)-monophos catalysed 1,3-dipolar cycloaddition. This
illustrates the potential of the presented method for appli-
cation to site and chemo-selective modification of DNA.
Experimental
General remarks
Reagents were purchased from Aldrich or Fluka and they were
used as received. 1H-NMR and 13C-NMR spectra were recorded
on a Varian AMX400 (400 and 100 MHz) in CDCl3.
Reversed phase-HPLC (RP-HPLC) analysis were performed on a
Shimadzu LC-10AD VP, Waters Xterra MS C18 column (3.0 ×
150 mm, particle size 3.5 μm) using a gradient of CH3CN/TEAA
(triethylammonium acetate) buﬀer 50 mM pH = 7 at 40 °C For
purification purposes Waters Xterra Prep MS C18 column
(7.8 × 150 mm, particle size 10 μm) at flow 1.0 mL min−1 was
used. Gradient A (general gradient unless noted otherwise):
CH3CN/TEAA buﬀer 50 mM pH = 7; gradient: 05/95 0 to
10 min, to 10/90 at 15 min, to 20/80 at 20 min to 30/70 at
30 min, to 50/50 at 50 min to 70/30 at 65 to 05/95 at 95 min for
15 min. Flow of 0.5 mL min−1 for analytical runs and flow of
1.0 mL min−1 for the preparative runs. MALDI-TOF measure-
ments were done on a Voyager-DE Pro apparatus (Matrix: 20 μL
of a solution of 2,4,6-trihydroxyacetophenone 0.5 M in EtOH +
10 μL of a solution of ammonium citrate dibasic 0.1 M in
double distilled (dd) H2O + 2 μL sample solution in dd H2O).
HRMS spectra were recorded on a LTQ XL Orbitrap from
Thermo Fisher Scientific. Oligo 1 (dTACTG) and oligo 2 (dAA-
TACGTG) were obtained from BioTez Berlin. Oligonucleotide
concentrations were determined using Nanodrop ND-100
from Thermo Fisher Scientific. Column chromatography was
performed on silica gel.
Synthesis of alkoxy amines
2-(Decyloxy)isoindoline-1,3-dione (9). To a solution of
1-bromodecane 8 (2.2 g, 10.0 mmol) and N-hydroxyphtalamide
(1.96 g, 12.0 mmol) in 50 mL DMF, K2CO3 (1.66 g, 12 mmol)
was added in two portions. The reaction mixture was allowed
to react overnight at room temperature. The solvent was evap-
orated under reduced pressure. The resulting solid was dis-
solved in dichloromethane (100 mL) and washed with H2O
(100 mL). After separation, the organic layer was washed with
H2O (2 × 30 mL) and with brine (2 × 30 mL). The organic layer
was dried over MgSO4 and concentrated under pressure to give
9 as white solid (2.54 g, 8.3 mmol, 83% yield) 1H NMR
(400 MHz, CDCl3): δ 7.83–7.86 (m, 2H), 7.73–7.75 (m, 2H), 4.19
(t, J = 6.8 Hz, 2H), 1.79 (m, 2H), 1.45 (m, 2H), 1.19–1.35
(m, 12H), 0.87 (t, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3):
δ 163.7, 134.4, 129.0, 123.5, 78.6, 31.9, 29.5, 29.46, 29.44, 29.3,
28.1, 25.5, 22.7, 14.1. HRMS (positive mode) (m/z) calculated
mass for C18H25N1O3Na [M + Na]
+ 326.17266, found mass
326.17242. mp = 72–73 °C.
O-Decylhydroxylamine (10). To a solution of 9 (2.12 g,
7.0 mmol) in 30 mL of dichloromethane, hydrazine hydrate
Scheme 4 Click reaction of M7A. Conditions: CuSO4 :monophos :
sodium ascorbate (1 : 1.1 : 10) (5 mol% copper), excess of alkyne.
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(0.7 mL, 14 mmol) was added drop wise. After stirring over-
night, the reaction was quenched with NaOH [1 M].
The organic layer was washed with H2O (2 × 30 mL), brine
(2 × 30 mL), dried over MgSO4 and concentrated under
reduced pressure. The crude solid was further purified by
column chromatography (n-hexane : ethyl acetate, 7 : 3) to give
10 as a colorless oil (0.83 g, 4.8 mmol. 69% yield). 1H NMR
(400 MHz, CDCl3): δ 5.34 (br s, 2H –ONH2), 3.65 (t, J = 6.7 Hz,
2H), 1.57 (m, 2H), 1.18–1.39 (s, 14H), 0.88 (t, J = 6.6 Hz, 3H).
13C NMR (101 MHz, CDCl3): δ 76.3, 32.0, 29.7, 29.6, 29.6, 29.4,
28.4, 26.1, 22.7, 14.5. HRMS (positive mode) (m/z) calculated
mass for C10H24NO [M + H]
+ 174.18524, found mass
174.18518.
The product was immediately converted to the corres-
ponding hydrochloride salt by treatment with of HCl [6 M].
After filtration, the white solid was lyophilized.
1-Azido-4-methylbenzene (12). Prepared following pub-
lished procedure.24 10 g (92.8 mmol) of p-toluidine was dis-
solved in 46 mL of a solution of H2O : HCl (1 : 1) at 0 °C.
Sodium nitrite (6.3 g, 92.8 mmol) dissolved in 26 mL of cold
H2O was added drop wise, followed by drop wise addition of
sodium azide (6.1 g, 92.8 mmol) in 58 mL H2O. After 1 h
CHCl3 (100 mL) was added. The aqueous phase was extracted
twice with CHCl3 (100 mL). The combined organic layers were
washed with H2O (2 × 30 mL) and dried over MgSO4, concen-
trated under pressure to give 12 as a brown oil (11.1 g,
79.1 mmol, 85%). 1H NMR (400 MHz, CDCl3): δ 7.17 (d, J =
8.0 Hz, 2H), 6.94 (d, J = 8.0 Hz, 2H), 2.35 (s, 3H). 13C NMR
(101 MHz, CDCl3): δ 137.1, 134.86, 130.3, 118.7, 20.5.
1-Azido-4-(bromomethyl)benzene (13). Prepared following a
published procedure.25 To a solution of 1-azido-4-methyl-
benzene (12) (7.14 g, 53.7 mmol) in benzene 200 mL under a
nitrogen atmosphere, N-bromosuccinimide (10.51 g, 59 mmol)
and AIBN 1.0 g were added. The reaction was heated under
reflux for 3 days. The solvent was evaporated under reduced
pressure. The resulting solid was dissolved in CH2Cl2
(100 mL). The organic layer was washed with H2O (2 × 30 mL)
and brine (2 × 30 mL), dried over MgSO4 and concentrated
under reduced pressure to give the crude product which was
further purified by column chromatography (petroleum ether)
to give 13 as a brown oil (7.8 g, 37.1 mmol, 69%). 1H NMR
(400 MHz, CDCl3): δ 7.39 (d, J = 12.4 Hz, 2H), 7.01 (d, J =
12 Hz, 2H), 4.48 (s, 2H). 13C NMR (101 MHz, CDCl3) δ = 139.9,
134.2, 130.6, 119.3, 32.9.
2-((4-Azidobenzyl)oxy)-isoindoline-1,3-dione (14). To a solu-
tion of 1-azido-4-(bromomethyl)benzene 13 (3.4 g, 16 mmol)
and N-hydroxyphtalamide (3.13 g, 19.2 mmol) in 50 mL DMF,
K2CO3 (2.65 g, 19.2 mmol) was added in two portions. The
reaction mixture reacted overnight. The solvent was evaporated
under reduced pressure. The resulting solid was partitioned in
CH2Cl2 (150 mL) and H2O (100 mL). The organic layer after
isolation, it was washed with brine (2 × 50 mL) and then it was
dried over MgSO4, concentrated under reduced pressure to
give 14 as a brown solid (3.5 g, 12.16 mmol, 76%). 1H NMR
(400 MHz, CDCl3): δ 7.87–7.69 (m, 4H), 7.52 (d, J = 7.2 Hz, 2H),
7.02 (d, J = 7.4 Hz, 2H), 5.17 (s, 2H). 13C NMR (101 MHz,
CDCl3): δ 163.3, 141.1, 134.5, 131.4, 130.1, 128.6, 123.4,
119.0, 78.8. HRMS (positive mode) (m/z) calculated mass for
C15H10N4O3Na [M + Na]
+ 317.06451, found mass 317.06436
mp = 163–164 °C.
O-(4-Azidobenzyl) hydroxylamine (15). To a solution 2-((4-azido-
benzyl)oxy)-isoindoline-1,3-dione 14 (3.2 g, 10.9 mmol) in
45 ml of CH2Cl2, hydrazine hydrate (1.04 mL, 33 mmol) was
added drop wise. After stirring overnight the reaction was
quenched with NaOH [1 M]. The organic layer was washed
with H2O (2 × 30 mL) and brine (2 × 30 mL). The organic
phase was dried over MgSO4 and concentrated under reduced
pressure to give 15 as yellow-brownish oil (1.1 g, 6.1 mmol,
56%). 1H NMR (400 MHz, CDCl3): δ 7.36 (d, J = 8.2 Hz, 2H),
7.03 (d, J = 8.0 Hz, 2H), 5.41 (br s, 2H –ONH2), 4.65 (s, 2H).
13C NMR (101 MHz, CDCl3): δ 139.7, 134.4, 129.9, 119.0, 77.2.
HRMS (positive mode) (m/z) calculated mass for C7H9N4O
[M + H]+ 165.07709, found mass 165.07690.
The product was immediately converted to the corres-
ponding hydrochloride salt by treatment with of HCl [6 M].
After filtration, the yellow solid was lyophilized.
DNA modifications
Stock solutions of reagents. The hydrochloride salts (com-
pounds 1–7) were dissolved in double distilled (dd) H2O and
brought to the desired pH by using NaOH [6 M]. The stock
solutions were stored at −20 °C.
The oligonucleotides were dissolved in ddH2O (final con-
centrations of 200 µM). The concentrations of the oligonucleo-
tides were determined from their UV/Vis absorptions at
260 nm (Nanodrop) using the calculated extinction
coeﬃcients.
Modification of oligo 1 with CH3ONH2·HCl; representative
procedure. 100 µL of oligo 1 was mixed with 100 µL of the
desired solution of methoxyamine hydrochloride (for final
concentrations see Table 1) at the indicated temperatures for
the indicated times. The products were purified by preparative
reversed phase HPLC (Xterra column gradient B was used:
CH3CN/TEAA buﬀer 50 mM pH = 7; gradient: 05/95 0 to
10 min, to 10/90 at 15 min, to 20/80 at 20 min to 30/70 at
30 min, to 50/50 at 50 min to 70/30 at 65 to 05/95 at 95 min for
15 min); flow of 0.5 mL min−1 for analytical runs and flow of
1.0 mL min−1 for the preparative column.) and the pure frac-
tions were lyophilized.
Purity of the samples was evaluated with analytical reversed
phase HPLC (gradient A) and the identity was confirmed with
MALDI-TOF:
M1A: Retention time 33.3 min. MALDI-TOF (m/z) found
1507 (calculated 1506).
M1B: Retention time 34.2 min. MALDI-TOF (m/z) found
1554 (calculated 1553).
Reaction of oligo 1 with 2. 100 µL of oligo 1 solution was
mixed with the desired volume (for final concentrations, see
Table 2) of O-decylhydroxylamine hydrochloride 5 ([0.7 M],
pH = 4). The reaction was followed by RP-HPLC and purified using
a preparative Xterra column. Gradient C was used: CH3CN/
TEAA buﬀer 50 mM pH = 7; gradient: 05/95 0 to 10 min, to
Organic & Biomolecular Chemistry Paper





























































































35/65 at 40 min, to 70/30 at 50 min to 05/95 at 55 min for
15 min. Flow: 0.5 mL min−1 for analytical runs and flow of
1.0 mL min−1 with the preparative column. The product frac-
tions were lyophilized.
M2A: Retention time (gradient C) = 35.2 min MALDI-TOF
(m/z) found 1632; calculated 1632.
M2B: Retention time (gradient C) = 40.3 min MALDI-TOF
(m/z) found 1808; calculated 1805.
Reaction of oligo 1 with 3 and 4. 100 µL of oligo 1 solution
was mixed with 100 µL of the solution of the alkoxyamine (3 or
4). Two diﬀerent stock solutions were prepared ([1 M] and
[2 M] solution at pH 4). The reactions were followed by
RP-HPLC. The reactions did not reach full conversion and
many side products were observed.
M3A: MALDI-TOF (m/z) 1537; calculated 1535.
M4A: MALDI-TOF (m/z) 1567; calculated 1563.
M6A/B: reaction of oligo 1 with benzyloxyamine hydrochlo-
ride (6). 500 µL of the stock solution of oligo 1 was mixed with
500 µL of the freshly prepared solution of 6 [1.0 M] at pH = 4,
50 °C. The reaction was followed by RP-HPLC and the products
were purified by preparative RP-HPLC.
M6A: Retention time 40.2 min. MALDI-TOF (m/z) 1585;
calculated 1582 (yield 12%).
M6B: Retention time 50.2 min. MALDI-TOF (m/z) 1706;
calculated 1705 (yield 2%).
Reaction of oligo 2 with benzyloxyamine hydrochloride
(6). To 200 µL of oligo 2 [200 µM] was added 200 µL of the
stock solution of alkoxyamine 6 ([1.0 M], pH = 4). The reaction
reached 90% conversion after 5 days. The product was ana-
lyzed and purified by RP-HPLC.
Retention time = 44.0 min MALDI-TOF (m/z) 2534; calcu-
lated 2538 (yield 10%).
M7A: reaction of oligo 1 with p-azidobenzyloxyamine hydro-
chloride (7). 500 µL of the stock solution of 7 ([0.5 M], pH = 4)
was added to 500 µL of the oligo 1 stock solution. The reaction
was followed by RP-HPLC and almost complete conversion
(98%) was achieved after 3 days. The product was purified by
size exclusion chromatography (Sephadex G 15, eluting with
TEAA buﬀer) and lyophilized to give M7A.
M7A: Retention time 43.5 min MALDI-TOF (m/z) 1624;
calculated 1623.
General procedure for click reaction
Before use, all the solutions were flushed with nitrogen for
10–15 min. The azido-modified M7A was dissolved in 600 µL
of ddH2O.
The catalyst solution was prepared by dissolving
CuSO4·5H2O (2.5 mg, 0.01 mmol) and sodium ascorbate
(19.8 mg, 0.1 mmol) in 1.5 mL of ddH2O, followed by addition
of monophos (4.1 mg) in 500 µL of DMSO. This solution was
allowed to stir for 10–15 min and then used in the click
reaction.
M8A. 100 µL (0.91 mmol) of phenylacetylene (15) was dis-
solved in 500 µL of DMSO. 100 µL of this solution was added
to the DNA solution and after stirring for 5 min, 125 µL of the
Cu(I) catalyst solution was added. The reaction was stirred for
2 h at room temperature. The mixture was lyophilized and
then purified by preparative reversed phase HPLC using gradi-
ent A, to give M8A (retention time = 50.5 min) in 15% yield
after 2 steps. MALDI-TOF (m/z) 1726; calculated 1725.
M9A. 2 mg (0.007 mmol) of the alkyne modified dansyl
derivative 16 was dissolved in 100 µL of DMSO. 100 µL of the
solution of the alkyne was added to the DNA and after 5 min
of stirring together, 125 µL of the Cu(I) catalyst solution was
added. The reaction was stirred for 2 h at room temperature
and was then lyophilized. Purification by preparative RP-HPLC
using gradient A (retention time = 53.0 min) furnished M9A in
a yield of 14% over 2 steps. MALDI-TOF (m/z) 1917; calculated
1911.
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